BVF »

Avalo Therapeutics Ord shares owned by BVF

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by BVF from 13F filings

Historical chart of BVF investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by BVF

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.1M 967k 9.46

More positions owned by BVF

Moonlake Immunotherapeutics Class A Ord (MLTX)
Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Mirum Pharmaceuticals (MIRM)
Tyra Biosciences (TYRA)
Olema Pharmaceuticals (OLMA)
Structure Therapeutics Sponsored Ads (GPCR)
Cullinan Oncology (CGEM)
Xoma Royalty Corporation Com New (XOMA)
Axsome Therapeutics (AXSM)
Protagonist Therapeutics (PTGX)
4d Molecular Therapeutics In (FDMT)
Ac Immune Sa SHS (ACIU)
Gh Research Ordinary Shares (GHRS)
Kura Oncology (KURA)

View all positions for BVF

Top funds holding Avalo Therapeutics Ord

Ikarian Capital
OrbiMed Advisors
RA Capital Management
BVF
Logos Global Management
Commodore Capital
Sio Capital Management
Affinity Asset Advisors
Vanguard Group
Geode Capital Management
Bank of America Corporation
BlackRock
BlackRock
Morgan Stanley
Efficient Wealth Management

View all funds holding Avalo Therapeutics Ord